126 related articles for article (PubMed ID: 37787935)
21. pHLIP®-mediated delivery of PEGylated liposomes to cancer cells.
Yao L; Daniels J; Wijesinghe D; Andreev OA; Reshetnyak YK
J Control Release; 2013 May; 167(3):228-37. PubMed ID: 23416366
[TBL] [Abstract][Full Text] [Related]
22. A novel approach to pH-Responsive targeted cancer Therapy: Inhibition of FaDu cancer cell proliferation with a pH low insertion Peptide-Conjugated DGAT1 inhibitor.
Deskeuvre M; Lan J; Messens J; Riant O; Feron O; Frédérick R
Int J Pharm; 2024 May; 657():124132. PubMed ID: 38641019
[TBL] [Abstract][Full Text] [Related]
23. Human IL18-IL2 fusion protein as a potential antitumor reagent by enhancing NK cell cytotoxicity and IFN-γ production.
Du G; Ye L; Zhang G; Dong Q; Liu K; Tian J
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1727-36. PubMed ID: 22699929
[TBL] [Abstract][Full Text] [Related]
24. Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapy.
Bai F; Niu Z; Tian H; Li S; Lv Z; Zhang T; Ren G; Li D
Immunol Lett; 2014; 159(1-2):36-46. PubMed ID: 24613899
[TBL] [Abstract][Full Text] [Related]
25. pH-Dependent Transmembrane Activity of Peptide-Functionalized Gold Nanostars for Computed Tomography/Photoacoustic Imaging and Photothermal Therapy.
Tian Y; Zhang Y; Teng Z; Tian W; Luo S; Kong X; Su X; Tang Y; Wang S; Lu G
ACS Appl Mater Interfaces; 2017 Jan; 9(3):2114-2122. PubMed ID: 28058834
[TBL] [Abstract][Full Text] [Related]
26. An IL-2 proaerolysin fusion toxin that selectively eliminates regulatory t cells to enhance antitumor immune response.
Rogers O; Yen H; Solomon A; Drake C; Denmeade S
Prostate; 2019 Jul; 79(10):1071-1078. PubMed ID: 31059598
[TBL] [Abstract][Full Text] [Related]
27. The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesions.
Tapmeier TT; Moshnikova A; Beech J; Allen D; Kinchesh P; Smart S; Harris A; McIntyre A; Engelman DM; Andreev OA; Reshetnyak YK; Muschel RJ
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9710-5. PubMed ID: 26195776
[TBL] [Abstract][Full Text] [Related]
28. pHLIP-mediated targeting of truncated tissue factor to tumor vessels causes vascular occlusion and impairs tumor growth.
Li S; Tian Y; Zhao Y; Zhang Y; Su S; Wang J; Wu M; Shi Q; Anderson GJ; Thomsen J; Zhao R; Ji T; Wang J; Nie G
Oncotarget; 2015 Sep; 6(27):23523-32. PubMed ID: 26143637
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment.
Chen Y; Su Y; Pang X; Song X; Zhao W; Yu M
Front Oncol; 2022; 12():869260. PubMed ID: 35530359
[TBL] [Abstract][Full Text] [Related]
30. An upconversion nanoplatform with extracellular pH-driven tumor-targeting ability for improved photodynamic therapy.
Ai F; Wang N; Zhang X; Sun T; Zhu Q; Kong W; Wang F; Zhu G
Nanoscale; 2018 Mar; 10(9):4432-4441. PubMed ID: 29451577
[TBL] [Abstract][Full Text] [Related]
31. Effective melanoma immunotherapy with interleukin-2 delivered by a novel polymeric nanoparticle.
Yao H; Ng SS; Huo LF; Chow BK; Shen Z; Yang M; Sze J; Ko O; Li M; Yue A; Lu LW; Bian XW; Kung HF; Lin MC
Mol Cancer Ther; 2011 Jun; 10(6):1082-92. PubMed ID: 21518728
[TBL] [Abstract][Full Text] [Related]
32. Comparative Study of Tumor Targeting and Biodistribution of pH (Low) Insertion Peptides (pHLIP(®) Peptides) Conjugated with Different Fluorescent Dyes.
Adochite RC; Moshnikova A; Golijanin J; Andreev OA; Katenka NV; Reshetnyak YK
Mol Imaging Biol; 2016 Oct; 18(5):686-96. PubMed ID: 27074841
[TBL] [Abstract][Full Text] [Related]
33. Decoration of Nanovesicles with pH (Low) Insertion Peptide (pHLIP) for Targeted Delivery.
Rinaldi F; Hanieh PN; Del Favero E; Rondelli V; Brocca P; Pereira MC; Andreev OA; Reshetnyak YK; Marianecci C; Carafa M
Nanoscale Res Lett; 2018 Dec; 13(1):391. PubMed ID: 30515583
[TBL] [Abstract][Full Text] [Related]
34. pHLIP-mediated translocation of membrane-impermeable molecules into cells.
Thévenin D; An M; Engelman DM
Chem Biol; 2009 Jul; 16(7):754-62. PubMed ID: 19635412
[TBL] [Abstract][Full Text] [Related]
35. Differential sensitivity of pHLIP to ester and ether lipids.
Rao BD; Chakraborty H; Chaudhuri A; Chattopadhyay A
Chem Phys Lipids; 2020 Jan; 226():104849. PubMed ID: 31836521
[TBL] [Abstract][Full Text] [Related]
36. An extracellular pH-driven targeted multifunctional manganese arsenite delivery system for tumor imaging and therapy.
Zhang K; Lin H; Mao J; Luo X; Wei R; Su Z; Zhou B; Li D; Gao J; Shan H
Biomater Sci; 2019 May; 7(6):2480-2490. PubMed ID: 30957825
[TBL] [Abstract][Full Text] [Related]
37. Noncanonical amino acids to improve the pH response of pHLIP insertion at tumor acidity.
Onyango JO; Chung MS; Eng CH; Klees LM; Langenbacher R; Yao L; An M
Angew Chem Int Ed Engl; 2015 Mar; 54(12):3658-3663. PubMed ID: 25650762
[TBL] [Abstract][Full Text] [Related]
38. pH-induced insertion of pHLIP into a lipid bilayer: In-situ SEIRAS characterization of a folding intermediate at neutral pH.
Ataka K; Drauschke J; Stulberg V; Koksch B; Heberle J
Biochim Biophys Acta Biomembr; 2022 Jun; 1864(6):183873. PubMed ID: 35104491
[TBL] [Abstract][Full Text] [Related]
39. Cancer cells targeting with genetically engineered constructs based on a pH-dependent membrane insertion peptide and fluorescent protein.
Frolova AY; Pakhomov AA; Kakuev DL; Sungurova AS; Deyev SM; Martynov VI
Biochem Biophys Res Commun; 2022 Jul; 612():141-146. PubMed ID: 35525198
[TBL] [Abstract][Full Text] [Related]
40. pHLIP-fused PD-L1 engages avelumab to elicit NK cytotoxicity under acidic conditions.
Feng J; Zheng H; Zhang Y; Wu H; Wang M; Sun Y; Zhang M; Xiao H; Qiao C; Wang J; Luo L; Li X; Feng J; Shi Y; Zheng Y; Wang Y; Sheng D; Chen G
Heliyon; 2024 May; 10(9):e30551. PubMed ID: 38756565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
